July 23, 2016
Recommended Topic Related To:

Adempas

"The US Food and Drug Administration (FDA) has approved a new inhaled combination bronchodilator for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), according to a company news "...

A A A

Adempas

PATIENT INFORMATION

No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.

Last reviewed on RxList: 5/27/2014
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.